Abstract
Peptic ulcers are circumscribed lesions of the alimentary mucosa that penetrate through to its muscular layer. They occur most commonly in the proximal duodenum and also in the lesser curvature of the stomach. These ulcers are always associated with acid and pepsin secretion, and seem to result from a disturbance in the balance between the ulcerogenic potential of such secretions and the protective effects of mucus production, membrane barriers to the acid and pepsin, and the regeneration of mucosal cells (Stedman, 1982; Shearman and Finlayson, 1982; Berkow, 1982; Lampe, 1986). Venables et al. (1978) noted that 10% of the population is said to suffer peptic ulceration at some time in their lives.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ash, A. S. F. and Schild, H. O.: Receptors mediating some actions of histamine. Br. J. Pharmacol. Chemother. 27:427–439, 1966.
Berkow, R., ed.: The Merck Manual, 14th Ed., Merck Sharp & Dohme Research Laboratories, Rahway, NJ, 1982.
Black, J., Gerskowitch, V. P., and Leff, P.: Reflections on the classification of histamine receptors, in Pharmacology of Histamine Receptors, C. R. Ganellin and M.E. Parsons, eds. pp. 1–9, Wright, PSG, Bristol, UK, 1982.
Black, J.W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., and Parsons, E. M.: Definition and antagonism of histamine H2-receptors. Nature 236: 385–390, 1972.
Black, J.W., Duncan, W. A. M., Emmett, J. C., Ganellin, C. R., Hesselbo, T., Parsons, M. E.,and Wyllie, J.H.: Metiamide: An orally active histamine H2-receptor antagonist. Agents Actions 3:133–137, 1973.
Blackwood, W. S., Maudgal, D. P., Pickard, R. G., Lawrence, D., and Northfield, T. C: Cimetidine in duodenal ulcer: Controlled trial. Lancet 2:174–176, 1976.
Bodemar, G. and Walan, A.: Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet 2:161–164, 1976.
Bradshaw, J., Brittain, R.T., Clitherow, J. W., Daly, M. J., Jack, D., Price, B. J., and Stables, R.: Ranitidine (AH 19065): A new potent, selective histamine H2-receptor antagonist. Br. J. Pharmacol. 66:464P, 1979.
Brimblecombe, R. W., Duncan, W. A. M., Durant, G.J., Emmett, J. G, Ganellin, C. R., and Parsons, M. E.: Cimetidine: A non-thiourea H2-receptor antagonist.J. Int. Med. Res. 3:86–92, 1975a.
Brimblecombe, R.W., Duncan, W. A. M., Durant, G. J., Ganellin, C. R., Parsons, M. E. and Black, J.W.: The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br. J. Pharmacol. 53:435,436,1975b.
Brimblecombe, R. W., Duncan, W. A. M., Durant, G. J., Emmett, J. C., Ganellin, C. R., Leslie, G. B., and Parsons, M. E.: Characterization and development of cimetidine as a histamine H2-receptor antagonist. Gastroenterology, 74:339–347, 1978.
Brogden, R. N., Heel, R. C., Speight, T. M., and Avery, G. S.: Cimetidine: A review of its pharmacological and therapeutic efficacy in peptic ulcer disease. Drugs 15:93–131, 1978.
Brogden, R. N., Carmine, A. A., Heel, R. C., Speight, T. M. and Avery, G. S.: Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24:267–303, 1982.
Burland, W. L., Duncan, W. A. M., Hesselbo, T., Mills, J. G., Sharpe, P. G, Haggie, S. J., and Wyllie, J. H.: Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br. J. Clin. Pharmacol. 2:481–486, 1975.
Code, G F.: Histamine and gastric secretion: A later look, 1955-1965. Fed. Proc. 24:1311–1321, 1965.
Duncan, W. A. M. and Parsons, M. E.: Reminiscences of the development of cimetidine. Gastroenterology 78:620–625, 1980.
Durant, G. J., Emmett, J. G, and Ganellin, G R.: Some chemical aspects of histamine H2-receptor antagonists, in International Symposium on Histamine H 2-Receptor Antagonists, C. J. Wood and M. A. Simkins, ed., pp. 13–21, SKF, London, 1973.
Durant, G. J., Parsons, M. E., and Black, J.W.: Potential histamine H2-receptor antagonists. 2. Nαguanylhistamine. J. Med. Chem. 18:830–833, 1975.
Dyck, W. P.: Cimetidine in management of peptic ulcer disease, in Symposium on New Methods of Treatment of Gastrointestinal Disease. Surg. Clin. North Am. 59:863–867, 1979.
Fleshier, B.: The impact of cimetidine on the treatment of acid-peptic disease. Primary Care 8:195–203, 1981.
Forrest, J. A. H., Shearman, D. J. C., Spence, R., and Celestin, L. R.: Neutropenia associated with metiamide. Lancet 1:392,393,1975.
Ganellin, C. R.: Cimetidine, in Chronicles of Drug Discovery, J. S. Bindra and D. Lednicer, eds., pp. 1–38, Wiley, New York, 1982.
Ganellin, C. R., Durant, G. J., and Emmett, J. C: Some chemical aspects of histamine H2-receptor antagonists. Fed. Proc. 35:1924–1930, 1976.
Haggie, S. J., Fermont, D. C., and Wyllie, J. H.: Treatment of duodenal ulcer with cimetidine. Lancet 1:983,984,1976.
Hirschowitz, B.I.: H2histamine receptors. Annu. Rev. Pharmacol. Toxkol. 19: 203–244, 1979.
Lampe, K. F., ed.: Drug Evaluations, 6th Ed., American Medical Association, Chicago, 1986.
Misiewicz, J. J.: Role of cimetidine in gastrointerestinal disease: Present status and future potential. Drugs 15:89–92, 1978.
Pounder, R. E., Williams, J. G., Milton-Thompson, G. J., and Misiewicz, J. J.: 24-Hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet 2:1069–1072, 1975.
Pounder, R. E., Hunt, R. H., Stekelman, M., Milton-Thompson, G. J., and Misiewicz, J. J.: Healing of gastric ulcer during treatment with cimetidine. Lancet 1:337–339, 1976.
Richardson, C T. and Peterson, W. L.: New agents for peptic ulcer therapy. Drug Ther. 12:145–151, 1982.
Rocha e Silva, M., ed.: Histamine and antihistamines, in Handbook of Experimental Pharmacology, vol. 18, Part 1, pp. 991, Springer-Verlag, New York, 1966.
Shearman, D. J. C. and Finlayson, N. D. G: Diseases of the Gastrointestinal Tract and Liver, Churchill Livingstone, Edinburgh, 1982.
Stedman’s Medical Dictionary, 24th Ed., Williams & Wilkins, Baltimore, 1982.
Thjodleifsson, B. and Wormsley, K. G.: Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man. Gut 16:501–508, 1975.
Thomas, J. M. and Misiewicz, G.: Histamine H2-receptor antagonists in the short-and long-term treatment of duodenal ulcer. Clin. Gasiroenterol.13: 501–542, 1984.
Venables, C. W., Stephen, J. G., Blair, E. L., Reed, J. D., and Saunders, J. D.: Cimetidine in the treatment of duodenal ulceration and the relationship of this therapy to surgical management, in Cimetidine, The Westminster Hospital Symposium, C. Wastell and P. Lance, eds., pp. 13–27, Churchill Livingstone, London, 1978.
Wyllie, J.H., Hesselbo, T., and Black, J.W.: Effects in man of histamine H2-receptor blockade by burimamide. Lancet 2:1117–1120, 1972.
Wyllie, J. H., Ealding, W. D. P., Hesselbo, T., and Black, J. W.: Inhibition of gastric secretion in man by metiamide: A new, orally active histamine H2-receptor antagonist. Gut 14:424, 1973.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maxwell, R.A., Eckhardt, S.B. (1990). Cimetidine. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0469-5_27
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6775-1
Online ISBN: 978-1-4612-0469-5
eBook Packages: Springer Book Archive